Søgeord

 


Søgning på udtrykket 'remdesivir' giver 22 resultater:


Dokumenter (2)

Version 3 (06.04.2020) Denne vejledning er tiltænkt initial diagnostik og behandling af formodet COVID-19. Virussygdommen er først beskrevet i januar 2020, og der er endnu sparsom evidens på en række områder. Denne retningslinje vil løbende b…

Antiviralt middel til behandling af hypoksisk COVID-19 pneumoni Version 1.7


Sider (0)


Kalender (0)


Nyt fra tidsskrifterne (10)

Der er mere end 10 resultater, måske du vil se flere resultater her?

International Journal of Infectious Diseases
30.06.2020

Clinical Infectious Diseases Advance Access
28.06.2020
AbstractWe report a case of a male with COVID-19 who developed acute hepatotoxicity related to remdesivir with probable interaction of P-glycoprotein (P-gp) inhibitors. Until further details upon this interaction become available, we recommend physic…

JAMA Current Issue
16.06.2020
This Viewpoint reviews the FDA’s May 2020 Emergency Use Authorization of the antiviral drug remdesivir for treatment of COVID-19 and discusses the need for a transparent distribution plan of a drug not otherwise available in the US and for which de…

Wiley: Journal of Medical Virology: Table of Contents
3.06.2020
Journal of Medical Virology, Accepted Article.

The Journal of Infectious Diseases Advance Access
1.06.2020
…(MARV) is a filovirus with documented human case-fatality rates of up to 90%. Here, we evaluated the therapeutic efficacy of remdesivir (GS-5734) in nonhuman primates experimentally infected with MARV. Beginning 4 or 5 days post-inoculation, cynomolg…

Latest Results for Infection
16.05.2020
…t, there is no definitive antiviral treatment for coronavirus disease 2019 (COVID-19). We describe our early experience with remdesivir in four critically ill COVID-19 patients. Patients received a 200 mg loading dose, followed by 100 mg daily intr…

Science Express TOC RSS Feed
1.05.2020
…risis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a target of the antiviral drug, Remdesivir. Here we report the cryo-EM structure of the SARS-CoV-2 RdRp either in the apo form at 2.8 Å resolution or in com…

The Lancet
29.04.2020
In The Lancet, Yeming Wang and colleagues1 report a randomised trial of remdesivir (200 mg on day 1 followed by 100 mg on days 2–10, in single daily infusions) versus placebo for adults with severe coronavirus disease 2019 (COVID-19) in ten hospita…

The Lancet
29.04.2020
In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits. However, the numerical reduction in time to clinical improvement in those treated earlier requir…

Critical Care Medicine - Online First
24.04.2020
…ll are unpaid positions. Dr. Frederick Hyden is non-compensated consultant to Gilead Sciences (antivirals for RVIS including remdesivir), Regeneraon (monoclonals for RVIs including MERS), and SAB Biotherapeutics (polyclonal antibodies for RVIs includ…


Aktuelle smitsomme sygdomme (10)

Der er mere end 10 resultater, måske du vil se flere resultater her?

HealthMap Global Disease Alerts
3.07.2020
…nUSAThe United States has bought nearly all the available global supplies for the next 3 months of anti-viral drug remdesivir, one of 2 drugs that have proven to be effective against COVID-19. The US Department of Health Services (HHS) anno…

Medscape Infectious Diseases Headlines
30.06.2020
The coronavirus stories Medscape's editors around the globe think you need to know about today.

Medscape Infectious Diseases Headlines
17.06.2020
Hospitals across the United States currently have access to the remdesivir they need to treat patients. But it's unclear when the next shipment is coming.

Medscape Infectious Diseases Headlines
3.06.2020
The results may not immediately affect the use of the drug, however, given current FDA guidance, limited supplies, and the challenges of administering an intravenous drug.

Medscape Infectious Diseases Headlines
23.05.2020
The results of the trial that prompted Dr Anthony Fauci to call remdesivir the "standard of care" for COVID-19 were published on Friday.

Medscape Infectious Diseases Headlines
23.05.2020
The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc’s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilatio…

Medscape Infectious Diseases Headlines
10.05.2020
These are the coronavirus stories you need to know about today.

Medscape Infectious Diseases Headlines
9.05.2020
The US Department of Health and Human Services releases an initial plan for the antiviral, but many questions remain.

Medscape Infectious Diseases Headlines
2.05.2020
These are the coronavirus stories you need to know about today.

Medscape Infectious Diseases Headlines
2.05.2020
The investigational antiviral drug remdesivir can now be used to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.

Nyhedsbrev


© 2020 Dansk Selskab for Infektionsmedicin

version: 2.7.1 ● design: C P Fischer

Side indlæst på 0,663 s

Cookies og privatliv